NO20020207L - Biological materials and methods useful in the diagnosis and treatment of disease - Google Patents

Biological materials and methods useful in the diagnosis and treatment of disease

Info

Publication number
NO20020207L
NO20020207L NO20020207A NO20020207A NO20020207L NO 20020207 L NO20020207 L NO 20020207L NO 20020207 A NO20020207 A NO 20020207A NO 20020207 A NO20020207 A NO 20020207A NO 20020207 L NO20020207 L NO 20020207L
Authority
NO
Norway
Prior art keywords
diagnosis
disease
treatment
biological materials
methods useful
Prior art date
Application number
NO20020207A
Other languages
Norwegian (no)
Other versions
NO20020207D0 (en
Inventor
John Collinge
Anthony Russell Clarke
Jonathan Peter Waltho
Graham Stuart Jackson
Laszlo Luis Pereira Hosszu
Original Assignee
Imp College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9917491.4A external-priority patent/GB9917491D0/en
Priority claimed from GBGB9917878.2A external-priority patent/GB9917878D0/en
Application filed by Imp College Innovations Ltd filed Critical Imp College Innovations Ltd
Publication of NO20020207D0 publication Critical patent/NO20020207D0/en
Publication of NO20020207L publication Critical patent/NO20020207L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20020207A 1999-07-27 2002-01-15 Biological materials and methods useful in the diagnosis and treatment of disease NO20020207L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9917491.4A GB9917491D0 (en) 1999-07-27 1999-07-27 Biological materials and methods useful in the diagnosis and treastment of diseases
GBGB9917878.2A GB9917878D0 (en) 1999-07-30 1999-07-30 Biological materials and methods useful in the diagnosis and treatment of diseases
PCT/GB2000/002873 WO2001007479A2 (en) 1999-07-27 2000-07-25 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases

Publications (2)

Publication Number Publication Date
NO20020207D0 NO20020207D0 (en) 2002-01-15
NO20020207L true NO20020207L (en) 2002-03-14

Family

ID=26315795

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020207A NO20020207L (en) 1999-07-27 2002-01-15 Biological materials and methods useful in the diagnosis and treatment of disease

Country Status (7)

Country Link
EP (1) EP1200469A2 (en)
JP (1) JP2003506327A (en)
AU (1) AU780414B2 (en)
BR (1) BR0012765A (en)
CA (1) CA2379237A1 (en)
NO (1) NO20020207L (en)
WO (1) WO2001007479A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU707484B2 (en) 1995-09-14 1999-07-08 Regents Of The University Of California, The Antibodies specific for native PrPsc
US6537548B1 (en) 2000-07-27 2003-03-25 The Regents Of The University Of California Antibodies specific for ungulate PrP
AU2002320045B2 (en) 2001-05-31 2008-05-08 Adlyfe, Inc. Misfolded protein sensor method
US20050026165A1 (en) 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
GB0227651D0 (en) * 2002-11-27 2003-01-08 Medical Res Council Prion
EP1457500A1 (en) * 2003-03-14 2004-09-15 University of Zurich Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalophathies
US7439041B2 (en) 2003-08-13 2008-10-21 Novartis Vaccines And Diagnostics, Inc. Prion-specific peptide reagents
AU2006214463B2 (en) 2005-02-15 2012-08-30 Presympto, Inc. Method for detecting misfolded proteins and prions
US7834144B2 (en) 2005-09-09 2010-11-16 Novartis Ag Prion-specific peptoid reagents
MX2009001079A (en) 2006-07-28 2009-02-10 Adlyfe Inc Peptide probes for diagnostics and therapeutics.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
EP0986396A4 (en) * 1997-06-02 2003-05-02 Univ California Prion protein modulator factor (ppmf) and prion resistant animals

Also Published As

Publication number Publication date
EP1200469A2 (en) 2002-05-02
AU6454200A (en) 2001-02-13
NO20020207D0 (en) 2002-01-15
JP2003506327A (en) 2003-02-18
WO2001007479A3 (en) 2001-08-23
AU780414B2 (en) 2005-03-17
BR0012765A (en) 2002-04-02
WO2001007479A2 (en) 2001-02-01
CA2379237A1 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
GB9925804D0 (en) Biological materials and method useful in the diagnosis and treatment of diseases
EE200100480A (en) Xenon for use in the treatment of nerve poisoning
AU2001275177A1 (en) Cardiac disease treatment and device
AU2001275176A1 (en) Cardiac disease treatment and device
AU2001281369A1 (en) Cardiac disease treatment and device
NO20022592D0 (en) Compounds and Methods for the Treatment and Diagnosis of Chlamydia Infections
NO20034430L (en) Thiohydantoins and their use in the treatment of diabetic bees
NO20034437D0 (en) Ganglioside-associated recombinant antibodies and their use in the diagnosis and treatment of tumors
AU7532601A (en) Materials and methods for the treatment of gastroesophageal reflux disease
NO20015542D0 (en) Process for the preparation and use of N-desmethylzopiclones
NO20021964D0 (en) Biological fluid treatment
NO20011409L (en) Pharmaceuticals for the treatment of Parkinson's disease, ADHD and microadenomas
GB0019302D0 (en) Biological materials and the use thereof for the treatment of disease
AU2001270484A1 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
NO20020207D0 (en) Biological materials and methods useful in the diagnosis and treatment of disease
ITTO20001156A0 (en) EQUIPMENT FOR THE DISGREGATION TREATMENT OF BIOLOGICAL SAMPLES AND DISGREGATION DEVICE FOR USE IN SAID EQUIPMENT.
EA200101260A1 (en) METHOD OF CHANGING THE PHYSICAL AND CHEMICAL AND / OR BIOLOGICAL PROPERTIES OF THE SUBSTANCE
NO20040659L (en) Isoxazolopyridinones and their use in the treatment of Parkinson's disease
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
EA200100544A1 (en) METHOD FOR EXPRESS DIAGNOSTICS OF PHYSIOLOGICAL CONDITION OF THE BIOLOGICAL OBJECT AND DEVICE FOR ITS IMPLEMENTATION
GB9906217D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9917878D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
PT1496884E (en) ASSOCIATION OF ANTITROMBOTIC AND ASPIRIN AND THEIR USE IN THE TREATMENT OF ATEROSCLEROSIS TROMBOTIC DISEASES.
ZA200301143B (en) Biological materials and methods useful in the diagnosis and treatment of diseases.
GB0113011D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application